Abstract
Gas6 (growth arrest-specific 6) is a unique protein belonging to the family of plasma vitamin K-dependent proteins and a ligand for the tyrosine kinase family (Tyro3, Axl, Mer). Gas6 bears a great structural resemblance to the anticoagulant protein S. Interestingly, in spite of the presence of a g-carboxyglutamic acid domain in its structure, Gas6 has not been discored to show any function in the coagulation cascade. Gas6 has been reported to participate in cell proliferation, apoptosis, chemotaxis, leukocyte migration, sequestration, platelet aggregation, vascular homeostasis, and inflammation. In addition, it plays a role in the activation of various kinds of cells, including platelets and endothelial and vascular smooth-muscle cells (VSMC). After it was demonstrated that Gas6 induces proliferation of VSMC and serum-starved NIH 3T3 (mouse embryonic fibroblast cell lines) fibroblasts, mitogenic effects of Gas6 were found in cultured mesangial cells. As a result, it has been reported to take part in various pathophysiological processes, for instance, atherosclerosis, renal diseases, cancer, and thrombosis. The main subject of the present review is the role Gas6 plays in renal diseases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Ang:
-
Angiotensin
- CKD:
-
Chronic kidney disease
- CR:
-
Chronic rejection
- DN:
-
Diabetic nephropathy
- DOCA:
-
Deoxycorticosterone acetate
- EC:
-
Endothelial cells
- ECM:
-
Extracellular matrix
- ELISA:
-
Enzyme-linked immunosorbent assay
- Gas6:
-
Growth arrest-specific gene protein 6
- GFR:
-
Glomerular filtration rate
- Gla:
-
g-Carboxyglutamic acid
- GN:
-
Glomerulonephritis
- GO:
-
Glycoxidized
- HD:
-
Hemodialysis
- IgAN:
-
IgA nephropathy
- IMT:
-
Intima-media thickening
- LDL:
-
Low-density lipoprotein
- MHC:
-
Myosin heavy chain
- MMCs:
-
Mouse mesangial cells
- MR:
-
Mineralocorticoid receptor
- NADPH:
-
Nicotinamide adenine dinucleotide phosphate
- NIH 3T3:
-
Mouse embryonic fibroblast cell lines
- NK:
-
Natural killer
- NTN:
-
Nephrotoxic nephritis
- NTS:
-
Nephrotoxic serum
- PDGF:
-
Platelet-derived growth factor
- PI3K:
-
Phosphatidylinositol-3-kinase
- RAAS:
-
Renin-angiotensin-aldosterone system
- RCC:
-
Renal cell carcinoma
- RTK:
-
Receptor tyrosine kinase
- RT-PCR:
-
Reverse transcription polymerase chain reaction
- SHGB:
-
Sex hormone-binding globulin
- STAT:
-
Signal transducers and activators of transcription
- STZ:
-
Streptozotocin
- TAM receptors:
-
Tyro3, Axl, and Mer receptors
- TGF-β:
-
Transforming growth factor beta
- TNF:
-
Tumor necrosis factor
- VKD:
-
Vitamin K-dependent
- VSMC:
-
Vascular smooth-muscle cells
References
Allen MP, Zeng C, Schneider K, et al. Growth arrest-specific gene 6 (Gas6)/adhesion related kinase (Ark) signaling promotes gonadotropin-releasing hormone neuronal survival via extracellular signal-regulated kinase (ERK) and Akt. Mol Endocrinol. 1999;13:191–201.
Angelillo-Scherrer A, García de Frutos P, Aparicio C, et al. Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis. Nat Med. 2001;7:215–21.
Angelillo-Scherrer A, Burnier L, Flores N, et al. Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy. J Clin Invest. 2005;115:237–46.
Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007;13:9–20.
Avanzi GC, Gallicchio M, Cavalloni G, et al. GAS6, the ligand of Axl and Rse receptors, is expressed in hematopoietic tissue but lacks mitogenic activity. Exp Hematol. 1997;25:1219–26.
Avanzi GC, Gallicchio M, Bottarel F, et al. GAS6 inhibits granulocyte adhesion to endothelial cells. Blood. 1998;91:2334–40.
Balogh I, Hafizi S, Stenhoff J, et al. Analysis of Gas6 in human platelets and plasma. Arterioscler Thromb Vasc Biol. 2005;25:1280–6.
Batchu SN, Hughso A, Gerloff J, et al. Role of Axl in early kidney inflammation and progression of salt-dependent hypertension. Hypertension. 2013;62:302–9.
Bellido-Martín L, Frutos PG. Vitamin K-dependent actions of Gas6. Vitam Horm. 2008;78:185–209.
Bellosta P, Costa M, Lin DA, et al. The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding. Mol Cell Biol. 1995;15:614–25.
Borgel D, Clauser S, Bornstain C, et al. Elevated growth-arrest-specific protein 6 plasma levels in patients with severe sepsis. Crit Care Med. 2006;34:219–22.
Caraux A, Lu Q, Fernandez N, et al. Natural killer cell differentiation driven by Tyro3 receptor tyrosine kinases. Nat Immunol. 2006;7:747–54.
Cavet ME, Smolock EM, Ozturk OH, et al. Gas6-axl receptor signaling is regulated by glucose in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2008;28:886–91.
Cavet ME, Smolock EM, Menon P, et al. Gas6-Axl pathway: the role of redox-dependent association of Axl with nonmuscle myosin IIB. Hypertension. 2010;56:105–11.
Clauser S, Bachelot-Lozat C, Fontana P, et al. Physiological plasma Gas6 levels do not influence platelet aggregation. Arterioscler Thromb Vasc Biol. 2006;26:e22.
Collett G, Wood A, Alexander MY, et al. Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes. Circ Res. 2003;92:1123–9.
Collett GD, Sage AP, Kirton JP, et al. Axl/phosphatidylinositol 3-kinase signaling inhibits mineral deposition by vascular smooth muscle cells. Circ Res. 2007;100:502–9.
Correll PH, Morrison AC, Lutz MA, et al. Receptor tyrosine kinases and the regulation of macrophage activation. J Leukoc Biol. 2004;75:731–7.
Couchie D, Lafdil F, Martin-Garcia N, et al. Expression and role of Gas6 protein and of its receptor Axl in hepatic regeneration from oval cells in the rat. Gastroenterology. 2005;129:1633–42.
Dahlbäck B, Villoutreix BO. Regulation of blood coagulation by the protein C anticoagulant pathway: novel insights into structure-function relationships and molecular recognition. Arterioscler Thromb Vasc Biol. 2005;25:1311–20.
Demarchi F, Verardo R, Varnum B, et al. Gas6 anti-apoptotic signaling requires NF-kappa B activation. J Biol Chem. 2001;276:31738–44.
Doi T. The contribution of mesangial cell proliferation to progressive glomerular injury. J Med Investig. 2001;48:1–4.
Donate-Correa J, Martín-Núñez E, Muros-de-Fuentes M, et al. Inflammatory cytokines in diabetic nephropathy. J Diabetes Res. 2015;2015:948417.
Erek-Toprak A, Bingol-Ozakpinar O, Karaca Z, et al. Association of plasma growth arrest-specific protein 6 (Gas6) concentrations with albuminuria in patients with type 2 diabetes. Ren Fail. 2014;36:737–42.
Erkoc R, Cikrikcioglu MA, Aintab E, et al. GAS6 intron 8 c.834+7G>A gene polymorphism in diabetic nephropathy, renal failure. Accepted 18 Mar 2015 ID:LRNF 2014 0756R1.
Folli F, Okada T, Perego C, et al. Altered insulin receptor signalling and β-cell cycle dynamics in type 2 diabetes mellitus. PLoS One. 2011;6(11):e28050.
Fridell YW, Villa Jr J, Attar EC, et al. GAS6 induces Axl-mediated chemotaxis of vascular smooth cells. J Biol Chem. 1998;273:7123–6.
Gallicchio M, Mitola S, Valdembri D, et al. Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor. Blood. 2005;105:1970–6.
Goruppi S, Ruaro E, Schneider C. Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts. Oncogene. 1996;12:471–80.
Goruppi S, Ruaro E, Varnum B. Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. Oncogene. 1999;18:4224–36.
Gould WR, Baxi SM, Schroeder R, et al. Gas6 receptors Axl, Sky and Mer enhance platelet activation and regulate thrombotic responses. J Thromb Haemost. 2005;3:733–41.
Gustafsson A, Boström AK, Ljungberg B, et al. Gas6 and the receptor tyrosine kinase Axl in clear cell renal cell carcinoma. PLoS One. 2009a;4:e7575.
Gustafsson A, Martuszewska D, Johansson M, et al. Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival. Clin Cancer Res. 2009b;15:4742–9.
Guttridge KL, Luft JC, Dawson TL, et al. Mer receptor tyrosine kinase signaling: prevention of apoptosis and alteration of cytoskeletal architecture without stimulation or proliferation. J Biol Chem. 2002;277:24057–66.
Hafizi S, Alindri F, Karlsson R, et al. Interaction of Axl receptor tyrosine kinase with C1-TEN, a novel C1 domain-containing protein with homology to tensin. Biochem Biophys Res Commun. 2002;299:793–800.
Hall MO, Prieto AL, Obin MS, et al. Outer segment phagocytosis by cultured retinal pigment epithelial cells requires Gas6. Exp Eye Res. 2001;73:509–20.
Hansson K, Stenflo J. Post-translational modifications in proteins involved in blood coagulation. J Thromb Haemost. 2005;3:2633–48.
Hasanbasic I, Cuerquis J, Varnum B, et al. Intracellular signaling pathways involved in Gas6-Axl-mediated survival of endothelial cells. Am J Physiol Heart Circ Physiol. 2004;287:1207–13.
He X, Shen L, Villoutreix BO, et al. Amino acid residues in thrombin-sensitive region and first epidermal growth factor domain of vitamin K-dependent protein S determining specificity of the activated protein C cofactor function. J Biol Chem. 1998;273:27449–58.
Huang M, Rigby AC, Morelli X, et al. Structural basis of membrane binding by Gla domains of vitamin K-dependent proteins. Nat Struct Biol. 2003;10:751–6.
International Diabetes Federation Diabetes Atlas, 6th ed. http://www.idf.org/diabetesatlas/6e/Update20124. Accessed March 2015.
Ishimoto Y, Nakano T. Release of a product of growth arrest-specific gene 6 from rat platelets. FEBS Lett. 2000;466:197–9.
Ishimoto Y, Ohashi K, Mizuno K, et al. Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem. 2000;127:411–7.
Jonasch E, Gao J, Rathmell WK. Renal cell carcinoma. BMJ. 2014;349:g4797.
Kawaguchi H, Katagir M, Chikazu D. Osteoclastic bone resorption through receptor tyrosine kinase and extracellular signal-regulated kinase signaling in mature osteoclasts. Mod Rheumatol. 2004;14:1–5.
Kim HA, Nam JY, Jung JY, et al. Serum growth arrest-specific protein 6 levels are elevated in adult-onset Still’s disease. Clin Rheumatol. 2014;33:865–8.
Konishi A, Aizawa T, Mohan A, et al. Hydrogen peroxide activates the Gas6-Axl pathway in vascular smooth muscle cells. J Biol Chem. 2004;279:28766–70.
Korshunov VA, Mohan AM, Georger MA, et al. Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res. 2006;98:1446–52.
Laurance S, Lemarié CA, Blostein MD, et al. Growth Arrest-Specific Gene 6 (gas6) and Vascular Hemostasis. Adv Nutr. 2012;3:196–203.
Lee IJ, Hilliard B, Swami A, et al. Growth arrest-specific gene 6 (Gas6) levels are elevated in patients with chronic renal failure. Nephrol Dial Transplant. 2012;27:4166–72.
Lemke G, Rothlin CV. Immunobiology of the TAM receptors. Nat Rev Immunol. 2008;8:327–36.
Li R, Chen J, Hammonds G, et al. Identification of Gas6 as a growth factor for human Schwann cells. J Neurosci. 1996;16:2012–9.
Lutgens E, García de Frutos P, Aparicio C. Gas6−/−/ApoE−/− mice develop a collagen-rich, disorganized plaque phenotype, prone to intra-plaque hemorrhage. Circulation. 2000;102:38.
Lyons TJ. Glycation and oxidation: a role in the pathogenesis of atherosclerosis. Am J Cardiol. 1993;71:26B–31.
Manfioletti G, Brancolini C, Avanzi G, et al. The protein encoded by a growth arrest-specific gene (Gas6) is a new member of the vitamin-K-dependent proteins related to protein-S, a negative coregulator in the blood-coagulation cascade. Mol Cell Biol. 1993;13:4976–85.
Maquoi E, Voros G, Carmeliet P, et al. Role of Gas-6 in adipogenesis and nutritionally induced adipose tissue development in mice. Arterioscler Thromb Vasc Biol. 2005;25:1002–7.
Melaragno MG, Wuthrich DA, Poppa V, et al. Increased expression of Axl tyrosine kinase after vascular injury and regulation by G protein-coupled receptor agonists in rats. Circ Res. 1998;83:697–704.
Mima A, Arai H, Matsubara T, et al. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Diabetes. 2008;57:1712–22.
Muñoz X, Obach V, Hurtado B, et al. Association of specific haplotypes of GAS6 gene with stroke. Thromb Haemost. 2007;98:406–12.
Murao K, Imachi H, Sayo Y, et al. A product of growth arrest-specific gene 6 modulates scavenger receptor expression in human vascular smooth muscle cells. FEBS Lett. 1999;459:363–6.
Nagai K, Arai H, Yanagita M, et al. Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy. J Biol Chem. 2003;278:18229–34.
Nagai K, Matsubara T, Mima A, et al. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Kidney Int. 2005;68:552–61.
Nagai K, Miyoshi M, Kake T, et al. Dual involvement of growth arrest-specific gene 6 in the early phase of human IgA nephropathy. PLoS One. 2013;8:e66759.
Nagata K, Ohashi K, Nakano T, et al. Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem. 1996;271:30022–7.
Nakano T, Higashino K, Kikuchi N, et al. Vascular smooth muscle cell-derived, Gla-containing growth-potentiating factor for Ca(2+)-mobilizing growth factors. J Biol Chem. 1995;270:5702–5.
Paul LC. Chronic renal transplant loss. Kidney Int. 1995;47:1491–9.
Sather S, Kenyon KD, Lefkowitz JB, et al. A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation. Blood. 2007;109:1026–33.
Schlessinger J, Ullrich A. Growth factor signaling by receptor tyrosine kinases. Neuron. 1992;9:383–91.
Schneider C, King RM, Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell. 1988;54:787–93.
Sen P, Wallet MA, Yi Z, et al. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood. 2007;109:653–60.
Shao WH, Zhen Y, Rosenbaum J, et al. A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis. Clin Immunol. 2010;136:236–44.
Shieh YS, Lai CY, Kao YR, et al. Expression of axl in lung adenocarcinoma and correlation with tumor progression. Neoplasia. 2005;7:1058–64.
Son BK, Kozaki K, Iijima K, et al. Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. Circ Res. 2006;98:1024–31.
Son BK, Kozaki K, Iijima K, et al. Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells. Eur J Pharmacol. 2007;556:1–8.
Stenhoff J, Dahlbäck B, Hafizi S. Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts. Biochem Biophys Res Commun. 2004;319:871–8.
Su AI, Cooke MP, Ching KA, et al. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci. 2002;99:4465–70.
Tjwa M, Bellido-Martin L, Lin Y, et al. Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytes. Blood. 2008;111:4096–105.
Topham PS, Csizmadia V, Soler D, et al. Lack of chemokine receptor CCR1 enhances Th1 responses and glomerular injury during nephrotoxic nephritis. J Clin Invest. 1999;104:1549–57.
Tumlin JA, Madaio MP, Hennigar R. Idiopathic IgA nephropathy: pathogenesis, histopathology, and therapeutic options. Clin J Am Soc Nephrol. 2007;2:1054–61.
Vajkoczy P, Knyazev P, Kunkel A, et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci. 2006;103:5799–804.
Valverde P. Effects of Gas6 and hydrogen peroxide in Axl ubiquitination and downregulation. Biochem Biophys Res Commun. 2005;333:180–5.
Van Ginkel PR, Gee RL, Shearer RL, et al. Expression of the receptor tyrosine kinase Axl promotes ocular melanoma cell survival. Cancer Res. 2004;64:128–34.
Vandivier RW, Henson PM, Douglas IS. Burying the dead: the impact of failed apoptotic cell removal (efferocytosis) on chronic inflammatory lung disease. Chest. 2006;129:1673–82.
Villoutreix BO, de Frutos G, Lovenklev P, et al. SHBG region of the anticoagulant cofactor protein S: secondary structure prediction, circular dichroism spectroscopy, and analysis of naturally occurring mutations. Proteins. 1997;29:478–91.
Waizenegger JS, Ben-Batalla I, Weinhold N, et al. Role of growth arrest-specific gene 6-Mer axis in multiple myeloma. Leukemia. 2015;29:696–704.
Walzer T, Vivier E. NK cell development: gas matters. Nat Immunol. 2006;7:702–4.
Wang H, Chen S, Chen Y, et al. The role of Tyro 3 subfamily receptors in the regulation of hemostasis and megakaryocytopoiesis. Haematologica. 2007;92:643–50.
Wu Y, Singh S, Georgescu MM, et al. A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells. J Cell Sci. 2005;118:539–53.
Wu X, Liu X, Koul S, et al. AXL kinase as a novel target for cancer therapy. Oncotarget. 2014;5:9546–63.
Yanagita M. Gas6, warfarin, and kidney diseases. Clin Exp Nephrol. 2004;8:304–9.
Yanagita M, Arai H, Ishii K, et al. Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis. Am J Pathol. 2001a;158:1423–32.
Yanagita M, Arai H, Nakano T, et al. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J Biol Chem. 2001b;276:42364–9.
Yanagita M, Ishimoto Y, Arai H, et al. Essential role of Gas6 for glomerular injury in nephrotoxic nephritis. J Clin Invest. 2002;110:239–46.
Zhang ZX, Huang X, Jiang J,et al. Natural killer cells mediate long-term kidney allograft ınjury. transplantation. 2015 Feb 25. [Epub ahead of print].
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media Dordrecht
About this entry
Cite this entry
Toprak, A.E. (2016). Plasma Growth Arrest-Specific Protein 6 (Gas6) as a Biomarker of Renal Diseases. In: Patel, V., Preedy, V. (eds) Biomarkers in Kidney Disease. Biomarkers in Disease: Methods, Discoveries and Applications. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7699-9_37
Download citation
DOI: https://doi.org/10.1007/978-94-007-7699-9_37
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7698-2
Online ISBN: 978-94-007-7699-9
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences